Barber Financial Group Inc. Reduces Stock Holdings in Cerner Co. (NASDAQ:CERN)
Barber Financial Group Inc. lowered its position in Cerner Co. (NASDAQ:CERN) by 17.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,585 shares of the company’s stock after selling 4,229 shares during the quarter. Barber Financial Group Inc.’s holdings in Cerner were worth $1,312,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in CERN. Nuveen Asset Management LLC grew its holdings in shares of Cerner by 28,932.0% in the second quarter. Nuveen Asset Management LLC now owns 2,380,911 shares of the company’s stock valued at $174,521,000 after purchasing an additional 2,372,710 shares during the period. AQR Capital Management LLC grew its holdings in shares of Cerner by 166.4% in the second quarter. AQR Capital Management LLC now owns 2,714,579 shares of the company’s stock valued at $195,721,000 after purchasing an additional 1,695,766 shares during the period. Invesco Ltd. grew its holdings in shares of Cerner by 21.4% in the second quarter. Invesco Ltd. now owns 5,931,690 shares of the company’s stock valued at $434,793,000 after purchasing an additional 1,044,715 shares during the period. Eagle Asset Management Inc. purchased a new stake in shares of Cerner in the third quarter valued at about $67,620,000. Finally, Man Group plc grew its holdings in shares of Cerner by 572.2% in the second quarter. Man Group plc now owns 1,103,741 shares of the company’s stock valued at $80,904,000 after purchasing an additional 939,552 shares during the period. 83.82% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts have commented on CERN shares. Wells Fargo & Co upped their target price on shares of Cerner from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 25th. Deutsche Bank started coverage on shares of Cerner in a research report on Thursday, September 26th. They issued a “buy” rating and a $82.00 target price on the stock. BidaskClub cut shares of Cerner from a “sell” rating to a “strong sell” rating in a research report on Friday, October 25th. ValuEngine cut shares of Cerner from a “buy” rating to a “hold” rating in a research report on Wednesday, September 4th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $82.00 target price (up previously from $76.00) on shares of Cerner in a research report on Friday, August 16th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $76.73.
Shares of CERN opened at $67.31 on Friday. The stock has a market capitalization of $21.11 billion, a PE ratio of 30.46, a P/E/G ratio of 2.11 and a beta of 0.92. Cerner Co. has a 1 year low of $48.78 and a 1 year high of $76.47. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.19 and a current ratio of 2.21. The company’s 50-day simple moving average is $67.42 and its 200-day simple moving average is $69.69.
Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Thursday, October 24th. The company reported $0.66 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.66. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Cerner had a net margin of 9.02% and a return on equity of 15.61%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 earnings per share. On average, sell-side analysts predict that Cerner Co. will post 2.41 earnings per share for the current year.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Further Reading: Market Capitalization – What it Means for Investors
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.